share_log

长药控股(300391.SZ)发布上半年业绩,净亏损1.53亿元,扩大530.08%

Changjiang Pharmaceutical Group (300391.SZ) has released its first-half performance, with a net loss of 0.153 billion yuan, an increase of 530.08%.

Zhitong Finance ·  Aug 29, 2024 14:56

Changjiang Pharmaceutical Group (300391.SZ) released its semi-annual report for 2024, with the company's revenue at 7365....

Zhìtōng Cáijīng APP News, Changjiang Pharmaceutical Group (300391.SZ) released its semi-annual report for 2024, with the company's revenue at 73.6537 million yuan, a year-on-year decrease of 84.53%. The net loss attributable to the shareholders of the listed company was 0.153 billion yuan, a year-on-year increase of 530.08%. The net loss attributable to the shareholders of the listed company, excluding non-recurring gains and losses, was 0.15 billion yuan, a year-on-year increase of 51.42%. The basic loss per share is 0.4355 yuan.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 317

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.